| Autor: |
Kurmaev DP; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru., Bulgakova SV; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru., Treneva EV; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru., Kosareva OV; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru., Sharonova LA; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru., Dolgikh YA; Samara State Medical University, 89 Chapaevskaya str., Samara 443099, Russian Federation, e-mail: geriatry@mail.ru. |
| Abstrakt: |
The new coronavirus infection COVID-19 causes damage to many organs and systems, is a multi-organ disease. Many researchers are studying the relationship of the new coronavirus infection with polymorbid pathology, frailty, sarcopenia. The SARS-CoV-2 virus has the property of neurotropism, therefore, olfactory, taste disorders, as well as cognitive impairments can join the spectrum of clinical manifestations and consequences of the disease. Alzheimer's disease is the most common cause of dementia in the world. It is of interest that there is a link between the coronavirus infection and the development of cognitive impairment, including Alzheimer's disease. |
